Instrument Business Outlook Volume 33 - Issue 22
-
IBO’s 2024 Company of the Year: Twist Bioscience
-
New Private Sector Labs
-
Correction: Labguru
-
Executive Briefing
-
Illumina Updates Guidance as China Officially Bans Illumina Sequencer Sales
-
Thermo Fisher to Make $4.1 Billion Acquisition
-
Parse Agrees to Injunction
-
908 Sells Bioprocessing Assets
-
Shareholder Challenges Quanterix Acquisition
-
Leica Buys Reagent Provider
-
Oxford Nanopore Announces Lay Offs
-
Revvity Wins Injunction
-
Promega Files Patent Infringement Suit
-
Water Quality Probe Company Sold
-
IBO Stock Indexes Impacted by Macroeconomic Concerns
-
Laboratory Instruments and Products Stock Index
-
Diversified Laboratory Stock Index
-
International Stocks
-
Market Profile: Windowless EDS
-
Leading Vendors
-
Largest Markets
-
Instrument Cost
-
Industry Watch
-
Government: NIH Indirect Costs Update
-
Semiconductors: 2024 Sales Show Major Gains
-
Clinical: MCED’s Progress
-
Region Watch
-
Egypt: New Universities
-
Spain: Biotech R&D
-
Europe: Science Funding
-
News
-
Broad-Based Company News
-
Sequencing
-
Company Announcements
-
Product Introductions
-
Sales & Orders of Note
-
Chromatography
-
Company Announcements
-
Product Introductions
-
Sales & Orders of Note
-
Spectroscopy
-
Company Announcements
-
Product Introductions
-
Sales & Orders of Note
-
Bottom Line